HealthLynked: The AI Platform Redefining Personal Care Management

Transforming Healthcare Through AI-Driven Precision and Prevention

​

Healthcare Apps are a rapidly growing tool that patients are discovering to help provide their healthcare needs with cost savings and the convenience a mobile phone.  TeleDoc Health, Inc. (TDOC: NYSE) claims over 93 million subscribers and Doximity, Inc. claims membership of over 80% of doctors and nurses.

​

As large as these apps are, they seem to fall short of the newly discovered tools offered by AI and more.

​

HealthLynked (OTCQB: HLYK) has been quietly building one of the most advanced consumer-facing healthcare platforms in the U.S., investing over $22 million in its development over the past several years. This foundational work positioned the company for its breakthrough — the launch of ARI, HealthLynked’s patented AI personal care management guide, introduced just seven months ago.

​

ARI represents the culmination of years of innovation: an intelligent, voice-enabled healthcare assistant designed to help users manage their care, identify early disease risks, and understand the potential causes of illness — all through personalized, real-time AI insights.

​

With this launch, HealthLynked has evolved from a data platform into a living, learning AI ecosystem that empowers consumers to take control of their health while helping physicians deliver better, faster, and more connected care.

​

AI That Learns From Every Patient — To Help All Patients

 

Every interaction within HealthLynked’s network — from medical visits to pharmacy use to telehealth sessions — feeds into its AI engine.

 

Over time, ARI continuously learns from this aggregated data, enabling the system to:

• Recognize correlations and underlying causes of disease.

• Deliver personalized prevention and treatment insights.

• Recommend care pathways based on real-world outcomes.

• Strengthen predictive analytics across the entire user base.​

 

This creates a self-improving healthcare network that gets smarter with every patient interaction — building collective intelligence designed to reduce costs and improve outcomes at scale.

​

From Cost Center to Care Partner

​

With insurance premiums and deductibles at historic highs, millions of Americans are effectively “underinsured.” HealthLynked addresses this gap directly. By combining AI-driven care guidance, telemedicine, pharmacy access, and medical supply discounts, the company enables consumers to access affordable, personalized healthcare — without the gatekeeping and inefficiency of traditional systems.

This transformation of patients from passive recipients to active participants represents a fundamental shift in healthcare economics — one that HealthLynked is leading.

​

Built for Engagement — Designed for Retention

​

HealthLynked’s strength lies in integration and engagement. Once users are in the ecosystem, switching away becomes unlikely.

AI-Driven Feature

Value Created

Personalized health insights

Drives recurring engagement

Unified health records

Raises switching costs

AI appointment routing & provider matching

Creates convenience and continuity

Network of 880,000+ providers

Builds data density and trust

​

Together, these create a “sticky” ecosystem that becomes each user’s healthcare home base — where their health data, records, and AI-driven recommendations converge.

​

Where the Investment Opportunity Lies

​

HealthLynked’s story is now entering the inflection phase. The platform is built. The data infrastructure and AI are live. The next step — mass adoption — will determine scale and valuation.

​

At a current market capitalization of under $5 million, the company sits at a rare juncture where its technology maturity far exceeds its market awareness. With ARI’s rollout gaining momentum, the asymmetry between potential and valuation presents a unique opportunity for investors positioned early.

​

Key drivers include:

• $22 million investment in platform development and infrastructure.

• Patented AI engine (ARI) launched 7 months ago.

• Integration across telehealth, pharmacy, and supply networks.

• Compliance with the U.S. “Kill the Clipboard” and interoperability mandates.

• Founder with a proven billion-dollar track record in healthcare.

 

Leadership with Proven Execution

​

Founder and CEO Dr. Michael Dent, who previously founded NeoGenomics, has a track record of transforming early-stage healthcare platforms into multi-billion-dollar public companies. Under his leadership, NeoGenomics became a category leader in precision medicine — and HealthLynked is following a similar trajectory, now powered by AI.

​

The Bottom Line

​

HealthLynked has spent years building — and investing — in the foundation of a smarter healthcare future. With the launch of ARI, its AI-driven personal care guide, the company is now activating that infrastructure to deliver personalized health management and disease-cause discovery at scale.

​

This is not a concept — it’s execution in motion.

The foundation is built, the AI is live, and the market is ready.

For investors, this is the moment before recognition meets valuation.

​

Legal Disclosures and Disclaimers

Green Planet Microcaps is not a registered investment adviser. The information that we provide from our website or newsletters is not, and should not be construed in any manner, to be investment advice. All opinions and information provided on this site are for educational and research purposes. Green Planet Microcaps encourages all readers to do their own due diligence and research when determining which investment strategies are best suited for them or to seek the advice of an investment professional.

​

Any information provided by Green Planet Microcaps should not be construed by any subscriber or prospective subscriber as a solicitation by Green Planet Microcaps to effect, or attempt to effect, any transaction in any security. Investments in the securities markets, and especially in private securities of small start-up companies, are incredibly and highly speculative and involve substantial risk that your entire investment could be lost. The information that we provide or that is derived from our website and/or newsletters should not be a substitute for advice from an investment professional. We encourage you to obtain personal advice from your professional investment advisor and to make independent investigations before acting on the information that you obtain from Green Planet Microcaps or derive from our website and/or newsletters. Only you can determine what level of risk is appropriate for you.

​

Specifically, we advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to purchase or trade in stocks or any securities presented on this website and/or in a particular newsletter. All information provided regarding the companies featured comes from the companies themselves, SEC filings, news releases, private placement memoranda, company websites as well as other sources of publicly available information. The profiles of these highlighted public and private companies are not in any way a solicitation or recommendation to buy, sell, or hold these or any other securities.

​

Most of the information on our website and/or newsletters or that we otherwise provide is derived directly from information published by the companies on which we report and/or from other sources we believe are reliable, without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. The information may contain discussions of, or provide access to, certain positions and recommendations as of a specific date. Due to various factors, including, but not limited to, changing market conditions, such discussions and positions/recommendations may no longer be reflective of current discussions and positions/recommendations. We do not in any way warrant or guarantee the success of nor endorse any action which you take in reliance on the information that we provide or that is derived from our website.

​

Investors should not rely solely on the information contained on this website or in any specific newsletter. Rather, investors should use the information contained on this Website and/or in newsletters as a starting point for doing additional independent research on the featured private and public companies. The advertisements within this newsletter are not to be construed as offers to purchase securities in the companies which may be the subject of such advertisements pursuant to federal or state law or the laws of any foreign jurisdiction.

Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects’”, “will,” “anticipates,” “estimates,” “believes,” “understands” or that by statements indicating certain actions “may,” “could,” or “might” occur. There is no guarantee past performance will be indicative of future results. The accuracy or completeness of the information in this newsletter is only as reliable as the sources they were obtained from.​ Green Planet Microcaps was compensated for this article and will not be liable for any consequential, incidental, punitive, special, exemplary or indirect damages resulting directly or indirectly from the use of or reliance upon any material provided by Green Planet Microcaps or derived from Green Planet Microcap’s website and/or newsletters. Green Planet Microcaps shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscriber’s inability to use or any delay in accessing Green Planet Microcaps website or any other source of material provided by Green Planet Microcaps including newsletters; (3) any absence of material on Green Planet Microcaps; (4) Green Planet Microcaps failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material. Green Planet Microcaps and each subscriber acknowledge that, without limitation, the above-enumerated conditions cannot be the probable result of any breach of any agreement between Green Planet Microcaps and the subscriber.

​

Green Planet Microcaps is not affiliated with any brokerage firm and does not endorse or recommend any specific brokerage firm. Green Planet Microcaps is not and will not be responsible for any trades made by a broker on the subscriber’s behalf under any circumstances.